YU103391A - Heterociklicni antraciklinoni i antraciklinski analozi - Google Patents

Heterociklicni antraciklinoni i antraciklinski analozi

Info

Publication number
YU103391A
YU103391A YU103391A YU103391A YU103391A YU 103391 A YU103391 A YU 103391A YU 103391 A YU103391 A YU 103391A YU 103391 A YU103391 A YU 103391A YU 103391 A YU103391 A YU 103391A
Authority
YU
Yugoslavia
Prior art keywords
heterocyclic
hydrogen
anthracyclinons
anthracyclinal
analysis
Prior art date
Application number
YU103391A
Other languages
English (en)
Inventor
G. Attardo
B. Belleau
Y.Ch. XU
J.F. Lavallee
R.N. Rej
Original Assignee
Jaf Biochem International Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jaf Biochem International Inc. filed Critical Jaf Biochem International Inc.
Publication of YU103391A publication Critical patent/YU103391A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Forms Removed On Construction Sites Or Auxiliary Members Thereof (AREA)

Abstract

HETEROCIKLIČNI ANTRACIKLINONI I ANTRACIKLINSKI ANALOZI, pronalazak opisuje heterociklične antraciklinone i antraciklinske analoge koji imaju sledeću opštu formulu u kojoj su X1 i X2 nezavisno odabrani iz grupe koja se sastoji od O, S i C=N(R), X3 je O,S,SO,SO2, NO, R1,R2,R3,R4,R5 i R8 su vodonik, hidroksil, C1-16 alkil, tosil, triflat, halogen, nitro, cijano, C1-16 acil, R6 je vodonik, C1-16 alkil, R'6 je vodonik, halogen, amino, hidroksi, Y i R7 su vodonik, halogen, hidroksil, cijano. Pomenuta jedinjenja su korisna pri lečenju kancerogenih oboljenja ili tumora.
YU103391A 1990-06-11 1991-06-11 Heterociklicni antraciklinoni i antraciklinski analozi YU103391A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53610790A 1990-06-11 1990-06-11

Publications (1)

Publication Number Publication Date
YU103391A true YU103391A (sh) 1994-04-05

Family

ID=24137175

Family Applications (1)

Application Number Title Priority Date Filing Date
YU103391A YU103391A (sh) 1990-06-11 1991-06-11 Heterociklicni antraciklinoni i antraciklinski analozi

Country Status (18)

Country Link
EP (1) EP0533744A1 (sh)
JP (1) JPH06504034A (sh)
CN (1) CN1058781A (sh)
AP (1) AP340A (sh)
AU (1) AU653348B2 (sh)
CA (1) CA2085120A1 (sh)
CS (1) CS178691A3 (sh)
FI (1) FI925611A0 (sh)
HU (1) HU9203720D0 (sh)
IE (1) IE911965A1 (sh)
IL (1) IL98460A0 (sh)
MA (1) MA22178A1 (sh)
NZ (1) NZ238490A (sh)
PL (1) PL297164A1 (sh)
PT (1) PT97931A (sh)
WO (1) WO1991019725A2 (sh)
YU (1) YU103391A (sh)
ZA (1) ZA914452B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606037A (en) * 1992-11-09 1997-02-25 Biochem Pharma Inc. Processes antineoplastic heteronaphthoquinones
AU5414094A (en) * 1992-11-09 1994-06-08 Biochem Pharma Inc. Antineoplastic heteronaphthoquinones
US5736523A (en) * 1992-11-09 1998-04-07 Biochem Pharma Inc. Antineoplastic heteronapthoquinones
WO1995012588A1 (en) * 1993-11-05 1995-05-11 Biochem Pharma Inc. Antineoplastic heteronaphthoquinones
IT1271689B (it) * 1994-08-04 1997-06-04 Menarini Farma Ind 8-fluoro-antracicline, loro processi di preparazione e composizioni farmaceutiche che le contengono
JP2021534196A (ja) 2018-08-23 2021-12-09 シージェン インコーポレイテッド 抗ｔｉｇｉｔ抗体
CN111087377B (zh) * 2020-03-19 2020-06-26 广东省微生物研究所（广东省微生物分析检测中心） 苯并异色满醌类化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52148088A (en) * 1976-06-01 1977-12-08 Richardson Merrell Inc 111aminoalkylmorphansridinee 111ols
JPS6030315B2 (ja) * 1976-06-01 1985-07-16 三井東圧化学株式会社 ４−ハロゲノメチルイソクマリン誘導体の製造法
GB2067552B (en) * 1980-01-16 1984-02-29 Erba Farmitalia Anthracyline derivatives
JPS60142976A (ja) * 1983-12-28 1985-07-29 Yoshinori Asakawa イソクマリン誘導体
PH25651A (en) * 1986-05-21 1991-08-21 Duphar Int Res New di, tetrahydroisoquinoline derivatives
JPH01238579A (ja) * 1988-03-18 1989-09-22 Yamanouchi Pharmaceut Co Ltd Ｙ−０５４６０ｍ−ａ物質及びその製造法
JPH08112310A (ja) * 1994-10-18 1996-05-07 New Oji Paper Co Ltd 使いすておむつ

Also Published As

Publication number Publication date
FI925611A (fi) 1992-12-10
HU9203720D0 (en) 1993-03-29
AP340A (en) 1994-05-13
AU8097391A (en) 1992-01-07
CS178691A3 (en) 1992-01-15
IL98460A0 (en) 1992-07-15
NZ238490A (en) 1994-03-25
PT97931A (pt) 1992-03-31
CA2085120A1 (en) 1991-12-12
ZA914452B (en) 1992-06-24
WO1991019725A3 (en) 1992-04-30
CN1058781A (zh) 1992-02-19
EP0533744A1 (en) 1993-03-31
MA22178A1 (fr) 1991-12-31
FI925611A0 (fi) 1992-12-10
AU653348B2 (en) 1994-09-29
JPH06504034A (ja) 1994-05-12
IE911965A1 (en) 1991-12-18
WO1991019725A2 (en) 1991-12-26
AP9100278A0 (en) 1991-07-31
PL297164A1 (sh) 1992-10-05

Similar Documents

Publication Publication Date Title
DE3270317D1 (en) Derivatives of amino acids and their therapeutic use
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
BR9813368A (pt) Composto, processo para a preparação do mesmo, e uso do mesmo, composição farmacêutica, e, processo para efetuar a imunossupressão.
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
SE8804586L (sv) 1,4-dihydro-4-oxonaftyridinderivat och salter daerav foerfarande foer framstaellning av dessa jaemte antibakteriella medel innefattande dessa
DK0623021T3 (da) 4"-deoxyerythromycinderivater
FI961507A (fi) Antrasyklinonijohdannaiset ja niiden käyttö amyloidoosissa
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
YU103391A (sh) Heterociklicni antraciklinoni i antraciklinski analozi
BR9407257A (pt) Composto do tipo bis-naftalimida composição farmacêutica processo para tratamento de um tumor em mamifero uso do composto do tipo bis-naftalimida e processo para a preparação compostos do tipo bis-naftalimida
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
IT1196423B (it) Benzotiazolin-composti
ES2173195T3 (es) Derivados de antraciclina.
NO964269D0 (no) 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksogluco-pyranosider, deres fremstilling og anvendelse
FI902901A0 (fi) Dibenzol/1,5/dioxocin-5-one-derivat, deras anvaendning i laekemedel och foerfarande foer deras framstaellning.
NO991581L (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
FI852743A0 (fi) Acetyleniska fenoxipropanolderivat och farmaceutiska kompositioner foer behandling av hypertoni.
SE9603285D0 (sv) New compounds
ATE247955T1 (de) Selenophen-antitumormittel
ES2041050T3 (es) Un procedimiento para la preparacion de un glicosido de antraciclina.
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
EP0068033A4 (en) N- (4-PHENYL-2-THIAZOLYL) CARBAMATE DERIVATIVES, PREPARATION METHOD AND MEDICINAL COMPOSITION CONTAINING THEM.
SE7801526L (sv) 2,4-diklorfenyl-imidazolyl-etanoner(oler) till anvendning som lelemedel och sett att framstella foreningarna
ES2060401T3 (es) Nuevos derivados de estroptograminas y su preparacion.